Panomics, Inc.

Main Activity in Nanotechnology
Material Manufacturer
About Company
Panomics is a privately-held life science company focused on parallel quantitative biology (PQB) a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. Panomics has grown rapidly on the value of QuantiGene and QuantiGene Plex, our proprietary bDNA technology for gene expression analysis in cell-based assays, as well as our signal transduction and transcription factor assays. The company recently launched Deliver X a new siRNA delivery reagent for non-cytotoxic transfection of RNAi reagents into primary cell lines, the first in a series of biomolecule delivery products. Panomics (formerly Genospectra) was founded in 2000 and is based in Fremont, CA.
Panomics, Inc.6519 Dumbarton Circle |
Share with friends:
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2025 Nanotechnology research | All rights reserved | Developed by Makovic.net